.

Make Better Decisions

  • Analyze global market entry opportunities
  • Identify first generic entrants
  • Uncover prior art in expired and abandoned patents

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

McKesson
Medtronic
Fish and Richardson
Chinese Patent Office
Federal Trade Commission
Merck
QuintilesIMS
Covington
Boehringer Ingelheim
Chubb

Generated: September 21, 2017

DrugPatentWatch Database Preview

ENTOCORT EC Drug Profile

« Back to Dashboard

Which patents cover Entocort Ec, and when can generic versions of Entocort Ec launch?

Entocort Ec is a drug marketed by Perrigo Pharma Intl and is included in one NDA.

The generic ingredient in ENTOCORT EC is budesonide. There are twenty drug master file entries for this compound. Thirty-seven suppliers are listed for this compound. Additional details are available on the budesonide profile page.

Summary for Tradename: ENTOCORT EC

Patents:0
Applicants:1
NDAs:1
Suppliers / Packagers: see list5
Bulk Api Vendors: see list32
Clinical Trials: see list7
Patent Applications: see list9,897
Formulation / Manufacturing:see details
Drug Prices:see details
DailyMed Link:ENTOCORT EC at DailyMed

Pharmacology for Tradename: ENTOCORT EC

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Perrigo Pharma Intl
ENTOCORT EC
budesonide
CAPSULE;ORAL021324-001Oct 2, 2001ABRXYesYes► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Expired Patents for Tradename: ENTOCORT EC

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Perrigo Pharma Intl
ENTOCORT EC
budesonide
CAPSULE;ORAL021324-001Oct 2, 2001► Subscribe► Subscribe
Perrigo Pharma Intl
ENTOCORT EC
budesonide
CAPSULE;ORAL021324-001Oct 2, 2001► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Paragraph IV activity for: ENTOCORT EC

Drugname Dosage Strength RLD Submissiondate
budesonideEnteric Coated Capsules3 mgEntocort EC2/1/2008
« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Moodys
Express Scripts
US Army
Harvard Business School
Accenture
Merck
Cipla
US Department of Justice
McKinsey
Healthtrust

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot